Doctor profile · Federal record
Dr. Martin Claiborne, MD
Dermatology Physician (CMS: Dermatology) · New Orleans, LA
- NPI 1699770214
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 47 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1477 Louisiana Ave, Ste 100
New Orleans, LA 701153505
(504) 895-4339
fax (504) 895-4322
Credentials & registration
- NPI registered
- June 2005 — 21 yrs on file
- Profile last updated
- July 28, 2010
- Year of graduation
- 1979 — 47 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Louisiana #013116
- Medicaid
- LA #1196355
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1699770214. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,144
Distinct HCPCS
10
Medicare allowed
$214,614
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 2,901 | 243 | $6 | |
17000 |
Destruction of precancer skin growth, 1 growth | 549 | 271 | $57 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 548 | 304 | $124 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 367 | 239 | $87 | |
96910 |
Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 142 | 13 | $95 | |
77401 |
Superficial and/or low voltage radiation treatment delivery | 121 | 15 | $38 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 85 | 15 | $1 | |
17110 |
Destruction of skin growth, 1-14 growths | 57 | 52 | $95 | |
11301 |
Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 51 | 50 | $105 | |
J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 48 | 34 | $7 |
In context: peer comparison
Among 14 peers in New Orleans Dermatology Physician, average services per provider: 116. This provider delivers 44× the peer median.Open Payments
Industry payments received
All-time total
$764
Transactions
29
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Ucb, INC. | 4 | $172.43 | |
| Janssen Biotech, INC. | 5 | $145.57 | |
| Lilly USA, LLC | 3 | $86.43 | |
| Genzyme Corporation | 3 | $70.97 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $70.89 | |
| Amgen INC. | 3 | $62.68 | |
| Abbvie INC. | 2 | $47.43 | |
| Verrica Pharmaceuticals INC. | 1 | $26.16 | |
| Regeneron Healthcare Solutions, INC. | 1 | $24.27 | |
| Pfizer INC. | 1 | $23.43 | |
| Journey Medical Corporation | 1 | $19.07 | |
| Dermavant Sciences, INC. | 1 | $14.59 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,011
Patients
632
Total drug cost
$23,667
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 227 | 154 | $1,938 |
| Clobetasol Propionate | Generic | 196 | 134 | $5,703 |
| Doxycycline Hyclate | Generic | 102 | 62 | $2,251 |
| Fluconazole | Generic | 76 | 37 | $2,732 |
| Hydroxyzine Hcl | Generic | 76 | 31 | $946 |
| Ketoconazole | Generic | 72 | 35 | $1,089 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 42 | 28 | $1,924 |
| Desonide | Generic | 40 | 28 | $1,749 |
| Mupirocin | Generic | 38 | 36 | $371 |
| Hydrocortisone | Generic | 36 | 27 | $771 |
Frequently asked questions
What is Dr. Martin Claiborne's medical specialty?
Dr. Martin Claiborne practices Dermatology Physician in New Orleans, LA.
Where does Dr. Martin Claiborne practice?
Dr. Martin Claiborne practices at 1477 Louisiana Ave, New Orleans, LA 701153505. Office phone: 5048954339.
What is Dr. Martin Claiborne's NPI?
Dr. Martin Claiborne's National Provider Identifier (NPI) is 1699770214, issued by NPPES.
Does Dr. Martin Claiborne accept Medicare assignment?
Yes. Dr. Martin Claiborne accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Martin Claiborne commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.